Mycobacterium chelonae
| style="background:#Template:Taxobox colour;"|Mycobacterium chelonae | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| style="background:#Template:Taxobox colour;" | Scientific classification | ||||||||||||||
| ||||||||||||||
| Binomial name | ||||||||||||||
| Mycobacterium chelonae Bergey et al. 1923, ATCC 35752 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]
Overview
Mycobacterium chelonae is a species of the phylum actinobacteria (Gram-positive bacteria with high guanine and cytosine content, one of the dominant phyla of all bacteria), belonging to the genus mycobacterium.
Mycobacterium chelonae is a rapidly growing mycobacterium, that is found all throughout the environment including sewage and tap water. It can occasionally cause opportunistic infections of humans.
It is grouped in Runyon group IV.
Type strain: strain CM 6388 = ATCC 35752 = CCUG 47445 = CIP 104535 = DSM 43804 = JCM 6388 = NCTC 946.
Treatment
Antimicrobial regimen
- Localized infections [1]
- Preferred regimen: Clarithromycin 500 mg PO twice daily
- Alternative regimen: Azithromycin
- Disseminated or extensive disease
- monotherapy
- Preferred regimen: Clarithromycin 500 mg PO twice daily
- multidrug therapy
- preferred regimen: Clarithromycin 500 mg PO BID AND Tobramycin 5 mg IV/kg/day OR Imipenem 0.5-1 g IV q6h OR Linezolid 600 mg IV/PO BID for 4-8 weeks
- Alternative regimen: Moxifloxacin 400 mg daily AND Linezolid 600 mg twice daily
- NOTE: Total treatment duration is 6 months
- Keratitis (LASIK-related)
- Preferred regimen: Clarithromycin 500 mg PO BID AND topicals (Tobramycin 0.3%, 2 gtts q4h AND Gatifloxacin 0.3%, 1 gtt q4h OR Moxifloxacin 0.5%, 1 gtt q4h)
References
- ↑ Bartlett, John (2012). Johns Hopkins ABX guide : diagnosis and treatment of infectious diseases. Burlington, MA: Jones and Bartlett Learning. ISBN 978-1449625580.